Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
Young Ho Lee, Gwan Gyu Song
Topics & Concepts
MedicineAdalimumabTofacitinibRheumatoid arthritisMethotrexateInternal medicinePlaceboPharmacologyGastroenterologyAlternative medicinePathologyRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research